Skip to main content
. 2005 Jun;79(11):6848–6858. doi: 10.1128/JVI.79.11.6848-6858.2005

FIG. 5.

FIG. 5.

Inhibition of Mip-1β-induced chemotaxis of human CD4+ T lymphocytes by anti-CCR5 mouse antibodies. Purified lymphocytes were incubated with Ig fractions (20 ng/ml) from antisera elicited by FHV-I2, FHV-WT, or the synthetic cyclic CCR589-102 peptide. Controls (Cntr) included lymphocytes treated with Ig fractions from NMS and lymphocytes without added antibodies. Means and standard errors from three replicates.

HHS Vulnerability Disclosure